Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA. [electronic resource]
Producer: 20190729Description: 531-546 p. digitalISSN:- 1178-2005
- Administration, Inhalation
- Adrenal Cortex Hormones -- administration & dosage
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Aged
- Beclomethasone -- administration & dosage
- Bronchodilator Agents -- administration & dosage
- Disease Progression
- Drug Combinations
- Female
- Forced Expiratory Volume
- Formoterol Fumarate -- administration & dosage
- Glycopyrrolate -- administration & dosage
- Humans
- Lung -- drug effects
- Male
- Middle Aged
- Muscarinic Antagonists -- administration & dosage
- Nebulizers and Vaporizers
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Randomized Controlled Trials as Topic
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.